VEMP

VEMP assesses vestibular function in patients with Type 2 diabetes and diabetic peripheral neuropathy (DPN) by measuring cervical and ocular vestibular evoked myogenic potentials (cVEMP and oVEMP) to evaluate saccular-spinal and utriculo-ocular pathways.

Key Features:

• Clinical Application: Detects VEMP abnormalities in patients with Type 2 Diabetes, with emphasis on those with diabetic peripheral neuropathy (DPN).
• Patient Cohort: Validated on a cohort of 89 patients grouped as no peripheral neuropathy (NDPN), asymptomatic neuropathy (SDPN), and symptomatic neuropathy (DPN), plus 42 healthy subjects as controls.
• Parameters Assessed: Analyzes latency parameters from VEMP plots—oVEMP n10 and p15, and cVEMP p13 and n23—with prolonged latencies observed in SDPN and DPN versus controls and NDPN.
• Correlation Analysis: Identifies significant correlations of p15, p13, and n23 with HbA1c, fasting blood glucose (FBG), and illness duration, and a positive correlation of oVEMP n10 with HbA1c and FBG.
• Predictive Modeling: Implements a nomogram incorporating FBG, HbA1c, HDL, TG, TC, LDL, and patient group classification to predict VEMP parameters.
• Model Validation: Demonstrates good accuracy for predicting the p13 latency parameter as assessed by receiver operating characteristic (ROC) analysis.

Scientific Applications:

• Diagnostic assessment: Objective evaluation of vestibular dysfunction in Type 2 diabetic patients, including those with DPN, using cVEMP and oVEMP latency measures.
• Biomarker association studies: Investigation of relationships between VEMP latency abnormalities and metabolic markers such as HbA1c and FBG, plus illness duration.
• Predictive risk stratification: Use of a multivariable nomogram to predict specific VEMP latency changes (notably p13) for clinical or research decision support.

Methodology:

Analysis of VEMP latency parameters (n10, p15, p13, n23) from cVEMP and oVEMP recordings, correlation analyses with HbA1c, FBG and illness duration, development of a nomogram including FBG, HbA1c, HDL, TG, TC, LDL and patient group classification, and validation by receiver operating characteristic (ROC) analysis.